Axial: https://linktr.ee/axialxyz
Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio, Seranova Bio, Delix Therapeutics, Simcha Therapeutics, among others often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company . We are excited to be in business with you - email us at info@axialvc.com
TopOMetry systematically learns and evaluates the latent dimensions of single-cell atlases led by Davi Sidarta-Oliveira & Licio Velloso https://www.biorxiv.org/content/10.1101/2022.03.14.484134v2
Vault: Regeneron
Scientist Stories: Terry Orr-Weaver, Cell Division and Chromosome Segregation
"The next challenge in biology. Well, there’s so many challenges, and so little time. The challenges of how we are formed. We’re making great progress on how development of a complex organism such as ourselves, with skin and hair and all these other different tissues develop from the 35,000 genes. We’re going to understand that and that’s going to underwrite a lot of development of new drugs and treatment for diseases but then we look at the real challenge and ultimate challenge. There’s nothing that a human biologist would like to study more than the brain, the human brain. It’s a fascinating organ."
- Phillip Sharp, Nobel Prize for discovering splicing and co-founder of Biogen
